Research & Development: Page 61
-
PharmaVoice Team/PharmaVoice
R&D: Regulatory
Pharmaceutical Regulations Become More Challenging As pharmaceutical regulations become more complex globally, regulatory professionals are challenged to stay abreast of new regulations to remain compliant. Now more than ever, global health authorities are looking for a comprehensive risk managem...
By Denise Myshko • Nov. 13, 2012 -
PharmaVoice Team/PharmaVoice
R&D: Outsourcing
Outsourcing Becomes Strategic Pharma and biotech companies are now looking to their outsourcing partners to also weigh in on critical strategic and execution decisions. Cost, time to market, and risk are causing more companies to reduce their reliance on internal R&D for innovation. Outsourci...
By Denise Myshko • Nov. 13, 2012 -
Explore the Trendline➔
Getty Images
TrendlineOncology R&D
Cancer research remains a prime focus for the industry and often leads to pharma’s most impactful breakthroughs.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
R&D: Technology
Technology in Clinical Trials Data are the lifeblood of a clinical trial, yet more information isn’t always the answer to improved productivity. Data are the glue that hold clinical trials together, says Colin Hill, CEO, president, chairman, and co-founder of GNS Healthcare. “Data are being creat...
By Denise Myshko • Nov. 13, 2012 -
PharmaVoice Team/PharmaVoice
R&D: Protocols
Optimizing Clinical Trials Experts say optimizing the various processes in clinical development is critical for the timely and efficient approval of new products. Over the past several years pharmaceutical companies have been facing increases in costs and delays in conducting their clinical trial...
By Denise Myshko • Nov. 13, 2012 -
PharmaVoice Team/PharmaVoice
The C-Suite: Corporate Strategies
A New Path Ahead According to a recent Quintiles New Health report, a lack of capital and the increased reluctance of payers to reimburse for new medications are serious concerns among biopharma companies. Everyone is in agreement that the current level of healthcare spending is unsustainable, an...
By PharmaVoice Team • Nov. 13, 2012 -
PharmaVoice Team/PharmaVoice
On the Calendar
The Calendar Industry Events and Conferences, including SPECIAL DISCOUNTS Coming ATTRACTIONS Social Media, Mobile & Gaming for Pharma: How To Develop, Monitor, & Execute Digital Strategies To Engage Your Audiences, Strengthen Brand Awareness & Maximize Your Communication & Marketi...
By Taren Grom • Nov. 8, 2012 -
PharmaVoice Team/PharmaVoice
UpFront
Awards… Honored by Working Mother Bayer has been recognized by Working Mother magazine as one of the nation’s 100 best companies for working mothers. This is the ninth time in the past 10 years the company has been recognized on the annual list Clinical Research Advantage Executive Honorod Clinic...
By Taren Grom • Nov. 8, 2012 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Volume 12 • Number 10 Publisher Lisa Banket Editor Taren Grom Creative Director Marah Walsh Managing Editor Denise Myshko Senior Editor Robin Features Editor Kim Ribbink Contributing Editor Carolyn Gretton Design Associate Ariel Medel National Account Managers Trish Kane, Cathy Tracy WEBCAST?NETW...
By Taren Grom • Nov. 8, 2012 -
PharmaVoice Team/PharmaVoice
China's Pharma Star Shines Bright
With a large patient population, government commitment to healthcare reform, a huge depth of scientific talent, and a powerful economy, China has been identified by many as the world’s most important emerging biopharma market. With a population of 1.3 billion people, China is both the world’s mos...
By Kim Ribbink • Sept. 27, 2012 -
PharmaVoice Team/PharmaVoice
Last Word
Developing a Patient-Centric Business Model Rob Bazemore, President of Janssen Biotech, discusses why and how the company is implementing a patient-centric focus throughout all levels of the company. PV: What does being patient-centric mean for Janssen Biotech? Bazemore: Patients are our top pri...
By Rob Basemore • Sept. 27, 2012 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharmaceutical Pool Dr. Lawrence Bloch Infinity Names Business Chief Lawrence Bloch, M.D., has joined Infinity Pharmaceuticals as executive VP, chief financial officer, and chief business officer. Dr. Bloch is responsible for the company’s corporate, financial, and business development strategies...
By Carolyn Gretton • Sept. 27, 2012 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
The Long Goodbye: Alzheimer’s Disease The numbers are almost as daunting as Alzheimer’s disease itself. Today, 5.4 million Americans are living with the disease. Every four seconds around the world, someone is diagnosed with dementia. According to Alzheimer’s Disease International, there are 7.7 ...
By Taren Grom • Sept. 27, 2012 -
PharmaVoice Team/PharmaVoice
Data Management and Functional Outsourcing
Mark Penniston, Senior VP & General Manager, Clinical Analytics, Theorem Clinical Research. Theorem Clinical Research is a leading midsized provider of comprehensive clinical research and development services with offices in more than 30 countries and a customer base comprised of some of th...
By Mark Penniston • Aug. 31, 2012 -
PharmaVoice Team/PharmaVoice
A single, Common User Identity: The Door to an Optimized User Experience
A Single, Common User Identity: The Door to an Optimized User Experience Investigators involved in clinical trials will tell you how important single sign-on would be to them. Speaking with investigational sites involved in multiple trials, they explain how operating multiple technology solutions...
By Bill Byrom • Aug. 31, 2012 -
PharmaVoice Team/PharmaVoice
Key Data Management Strategies for Successful Late-Phase Studies
Late-phase studies present a set of unique goals and challenges unlike those in earlier phase clinical trials. Because this brand of research strives to reflect the real world, study designs are varied, data may be unavailable, and the uncontrolled environment may present unexpected results. At t...
By Steve Gulyas • Aug. 31, 2012 -
PharmaVoice Team/PharmaVoice
Preparing for Big Data: Laying the Foundation with Master Data Management
Preparing for Big Data: Laying the Foundation with Master Data Management Experts John Busalacchi, Senior Principal, IMS?Health. IMS Health is a leading provider of information, services and technology for the healthcare industry, covering markets in 100-plus countries around the world. For mor...
By John Busalacchi Senior Principal • Aug. 31, 2012 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Data Management: The Dynamics of Data Management
Carrie Coutre, director, study standards implementation (SSI) operations, for Millennium: The Takeda Oncology Company, says while the traditional data management resides with the CRO, Millennium’s SSI operations department works with the CRO as the liaison for data quality and all data-related ac...
By Carolyn Gretton • Aug. 31, 2012 -
PharmaVoice Team/PharmaVoice
Coming of Age: India Grows in Stature
India’s pharmaceutical industry is now the third largest in the world in terms of volume and stands 14th in terms of value. The country’s pharmaceutical market is expected to reach $55 billion in 2020 from $12.6 billion in 2009. And with a population of 1.1 billion, India is predicted to be the m...
By Kim Ribbink • Aug. 30, 2012 -
PharmaVoice Team/PharmaVoice
Companion Diagnostics: Partnering for Success
As the development of personalized medicine gains momentum, device and pharmaceutical companies are collaborating in their development efforts. They are creating partnerships for the development of diagnostics to accompany clinical trials. In fact, there has been an acceleration of companion diag...
By Denise Myshko • Aug. 30, 2012 -
PharmaVoice Team/PharmaVoice
Patient E-ngagement: A Marriage Made in Cyber Space
It wasn’t very long ago that industry involvement with social media consisted of only what our experts call “buzz monitoring," or the analysis and interpretation of patients’ public comments in online communities. While this practice was a good place to start, the industry is set to take the next...
By Robin Robinson • Aug. 30, 2012 -
PharmaVoice Team/PharmaVoice
Last Word
Continuing Efforts Toward Data Standardization Paula Brown Stafford, President of Clinical Development at Quintiles and Chair of the CDISC Board of Directors, shares her thoughts on data standardization. PV: Why is data standardization so important? Brown Stafford: Lack of standardization ofte...
By Paula Brown Stafford • Aug. 30, 2012 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharmaceutical POOL Dr. Dipak PANIGRAHI Silvia TAYLOR Sucampo Names Executives Global pharmaceutical firm Sucampo Pharmaceuticals has added two VPs to its leadership team. Sucampo has appointed Dipak Panigrahi, M.D., VP, medical affairs. Dr. Panigrahi’s responsibilities include establishing and l...
By Carolyn Gretton • Aug. 30, 2012 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: Compliance Programs Make Room for Integrity Agreements Use of PROs in Product Evaluations on the Rise Other market insights… Patent Cliff Hits Global Pharma Market Growth Declining R&D Budgets Drive Drug Discovery Ou...
By Carolyn Gretton • Aug. 30, 2012 -
PharmaVoice Team/PharmaVoice
What's New
New Healthcare-related Products, Services, and Companies Featured Briefs: Core-Create Merges with Brandkarma CST Supports Established Pharmaceutical, OTC Brands In other news… HHS Creates New Centers for Medical Countermeasures AROUND THE GLOBE The Core Nation’s healthcare marketing communicatio...
By Carolyn Gretton • Aug. 30, 2012 -
PharmaVoice Team/PharmaVoice
UpFront
Awards… Abbott Named One of the Best Workplaces in Europe The Great Place to Work Institute named Abbott one of the Best Multinational Workplaces in Europe. The company was specifically honored for workplace leadership in Belgium, Denmark, Ireland, Norway, and Portugal. This is the third conse...
By Taren Grom • Aug. 30, 2012
Previous
